Charterhouse Capital Partners
Charterhouse Capital Partners is a London-based private equity firm investing in European mid-market companies.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Charterhouse Capital Partners is a London-based private equity investment firm focused on the European mid-market. The firm invests in businesses generally valued between approximately €200 million and €1.5 billion, with activity spanning services, healthcare, specialised industrials and consumer-related sectors. Rather than selling consumer products under its own name, Charterhouse operates as an investment brand: it raises and deploys capital, partners with management teams, supports operational development and ultimately seeks to realise investments through sales, recapitalisations or public-market transactions. The organisation traces its origins to 1934 and is regarded as one of Europe's older private equity houses. Its predecessors operated as a division of Charterhouse Bank, later associated with HSBC. The investment operation began raising third-party equity in 1976, marking a transition from proprietary or bank-related activity toward institutional private equity. In June 2001, the management team completed a buyout from HSBC, creating an independent investment firm owned and operated separately from the bank. Charterhouse's portfolio history illustrates a broad European buyout strategy. Its investments have included environmental and technical consulting, business-process services, healthcare and specialty pharmaceuticals, insurance broking, software, certification, consumer goods, food distribution, industrial materials and exhibition businesses. Notable holdings have included Wood Mackenzie, Deb Group, Card Factory, ERM, Webhelp, Doc Generici, Armacell, Mirion Technologies, Cooper, SERB, Siaci Saint Honore, SLR Consulting, Nuova Castelli, Vermeg, Amtivo Group, Tarsus Group, Sagemcom and France Valley Investissements. The firm has frequently pursued majority or controlling positions while retaining management continuity and using acquisitions to build larger platforms. Several portfolio companies expanded through add-on acquisitions during Charterhouse ownership. Examples include Amtivo, which had acquired more than 20 businesses by the time of its 2022 transaction, and SERB, which expanded its specialty-pharmaceutical activities through the acquisition of Boston Scientific's BTG specialty-pharma unit. Charterhouse has also supported exits to other private equity sponsors, strategic buyers and continuation vehicles. Examples include the sale of Armacell to a Blackstone-led partnership, ERM to OMERS, Webhelp to KKR, SLR Consulting to an Ares Management fund and Sagemcom to a continuation fund backed by AlpInvest Partners. The firm's investment profile is defined by sector diversification, a European geographic focus and a preference for established mid-sized companies rather than early-stage venture investments. Its public identity is consequently tied less to a single flagship product than to a portfolio-building model and a long record of ownership transitions. As a private firm, Charterhouse does not have a publicly traded ticker, and detailed current information about its executives, assets under management and investment performance is not established in the supplied reference material.
History
Charterhouse Capital Partners originated in 1934 and developed from the investment activities associated with Charterhouse Bank. The firm's predecessors began raising third-party equity in 1976, an important step toward the institutional private equity model that later defined the business. The investment operation subsequently became connected with HSBC. In June 2001, its management completed a buyout from HSBC, establishing Charterhouse as an independent investment firm. Following independence, Charterhouse built a strategy around European mid-market companies, generally targeting businesses with enterprise values of roughly €200 million to €1.5 billion. Its preferred sectors have included services, healthcare, specialised industrials and consumer products. The firm has typically invested alongside management teams and sought to develop portfolio companies through organic expansion, operational improvement and acquisitions. During the late 2000s and 2010s, Charterhouse completed investments across a wide range of industries. It acquired Wood Mackenzie in 2009 and exited to Hellman & Friedman in 2012. In 2010 it acquired skincare group Deb Group and retailer Card Factory; both investments were exited in 2015. Other important transactions included the acquisitions of environmental consultancy ERM and customer-services company Webhelp in 2011, followed by exits to OMERS and KKR respectively in 2015. Charterhouse acquired Italian pharmaceutical company Doc Generici in 2013 and sold it to CVC Capital Partners in 2016. Industrial materials manufacturer Armacell became another notable investment. Charterhouse acquired the company in 2013 for a reported €520 million and sold it in 2015 to a Blackstone-led partnership in a transaction valued at approximately €960 million. In 2015, Charterhouse acquired Mirion Technologies, a radiation-detection specialist, for a reported $750 million. Mirion later announced plans to become publicly traded through a merger with a Goldman Sachs-backed special-purpose acquisition company, with the transaction valued at approximately $2.6 billion. Charterhouse continued its healthcare and business-services activity in the second half of the 2010s. It acquired Cooper, an over-the-counter self-care pharmaceutical provider, in 2016 and sold a majority stake to CVC in 2021. It acquired a majority stake in specialty-pharmaceutical company SERB in 2017 and a majority stake in French insurance broker Siaci Saint Honore in 2018. The firm also acquired SLR Consulting in 2018, disposed of cheese producer and distributor Nuova Castelli to Lactalis Group Italia in 2019, and invested in software company Vermeg and pension-services provider Lane Clark & Peacock in 2020. SERB's acquisition of Boston Scientific's BTG specialty-pharma unit was agreed in December 2020, while Charterhouse-backed transactions also included the acquisition of a minority interest in Vermeg from Crédit Mutuel Arkéa. In 2021, Charterhouse sold its majority stake in Cooper to CVC and its interest in Siaci Saint Honore to a consortium led by Burrus Group. In 2022, it sold SLR Consulting to an Ares Management fund and acquired Amtivo Group from August Equity. Amtivo continued a consolidation strategy in certification and related services, having acquired more than 20 businesses since its founding in 2017. In 2023, Charterhouse sold Tarsus Group to Informa in a cash-and-shares transaction reported at approximately £790 million. It also completed the sale of French telecommunications-equipment company Sagemcom to a continuation fund backed by AlpInvest Partners. In the same period, Charterhouse supported a management buyout of France Valley Investissements with the company's management team. These transactions demonstrate the firm's continuing use of sponsor-backed acquisitions, management partnerships, strategic disposals and continuation structures as part of its European private equity model.
- 2023
Tarsus sale and France Valley investment
[1]Charterhouse sold Tarsus Group to Informa and backed a management buyout of France Valley Investissements.
- 2020
Expansion in pharmaceuticals and software
[1]Charterhouse-backed SERB agreed to acquire BTG's specialty-pharma unit, while Charterhouse also invested in Vermeg and Lane Clark & Peacock.
- 2015
Multiple portfolio exits
[1]Charterhouse exited investments in Deb Group, Card Factory, ERM and Webhelp during a significant year of realisations.
- 2001
Management buyout from HSBC
[1]Management completed a buyout from HSBC, creating an independent investment firm.
- 1976
Third-party equity fundraising begins
[1]Predecessors of the modern firm began raising equity from third-party investors.
- 1934
Origins established
[1]The organisation traces its origins to investment activities associated with Charterhouse Bank.
Products and positioning
An independent European mid-market private equity investor with a long operating history, sector diversification and a buy-and-build orientation.
Product categories. European mid-market private equity investments · Buyout and growth capital for established companies · Portfolio-company acquisition and operational development · Investment realisation through strategic sales, sponsor exits and continuation transactions
Brand decisions
2022
Acquisition of Amtivo GroupM&ABackground
Amtivo had developed a certification-services platform through acquisitions since its founding in 2017.
Action taken
Charterhouse acquired Amtivo from August Equity, with August Equity retaining a minority interest through reinvestment.
Aftermath
Amtivo remained positioned as a consolidation platform in certification and related services.
2001
Transition to independent private equity ownershipStrategyBackground
The investment business had been associated with Charterhouse Bank and HSBC before management pursued an independent ownership structure.
Action taken
Management completed a buyout from HSBC and established Charterhouse as an independent investment firm.
Aftermath
The firm continued operating as an independent European mid-market private equity investor.
Recent events
- 2023
Charterhouse sells Tarsus Group to Informa[1]
M&A
Charterhouse completed the sale of Irish-based events and exhibitions business Tarsus Group to Informa in a cash-and-shares transaction.
- 2023
Charterhouse supports France Valley management buyout[1]
M&A
Charterhouse confirmed an investment supporting a management buyout of France Valley Investissements, a French forestry and real-assets manager.
- 2022
Charterhouse sells SLR Consulting to an Ares Management fund[1]
M&A
Charterhouse disposed of environmental consultancy SLR Consulting to a private equity fund managed by Ares Management.
- 2022
Charterhouse acquires Amtivo Group[1]
M&A
Charterhouse acquired certification and related-services provider Amtivo Group from August Equity, while August Equity reinvested for a minority position.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/charterhouse-capital-partners · Editorial policy · How profiles are compiled